Icahn’s Biogen blunder
Biogen Idec (BIIB) shares plunged after the biotech took itself off the block, saying that even after a two-month-long strategic review conducted by Goldman Sachs and Merrill Lynch it “did not receive any definitive offers to purchase the company.”
The decision, and the resulting 26 percent drop in the stock in Wednesday’s after-hours trading, won’t make any shareholders happy, but activist investor Carl Icahn seems likely to be particularly peeved. Icahn earlier this year took a substantial stake in the maker of the Tysabri treatment for multiple sclerosis and said he’d be willing to pay $80 a share for the whole company. Now the stock is fetching $56. That’s above its level back in the second quarter, when Icahn began building his stake - meaning he’s still likely to be ahead on the investment - but a far cry from the mid-80s where it traded at the height of the buyout rumor frenzy.
The stock’s slide brings to mind a comment analyst Caroline Stewart of Piper Jaffray made back in October, according to Fortune’s John Simons. “It’s crazy,” she said, “to suddenly say the stock is worth $20 more just because Carl Icahn says it is.” How right she was.
- So the Citi deal backed by the FDIC w... More
- This is why Government should only do... More
- I am a big fan of Buffet, but at the... More
- Miller - you are a fool. GE employs 3... More
- Treat the employees like sh!t and wha... More
- As a homeowner (barely), I should hav... More
- I wonder if there will ever be any tr... More
- Gifting WB to citi was a rip off of t... More
- If it dipped 15%, Buffett will probab... More
- Why is citi spending money on somethi... More
- Accrued Interest
- Aleph Blog
- Bespoke Investment Group
- Big Picture
- Calculated Risk
- Dealbook
- Econbrowser
- Felix Salmon
- Financial Armageddon
- Footnoted
- FT Alphaville
- Infectious Greed
- Naked Capitalism
- RGE Monitor
- Seeking Alpha
- Information Arbitrage
- Mish's Global Economic Trend Analysis
- Fortune on CNNMoney.com





I say to sell it to icahn for 80.00 a share. He probably doesn’t want it now that he made a bundle by selling it.